Boehringer Ingelheim Investigational Site

Calgary, Alberta T2N 2T9

0 studies enrolling now · 4 studies all time

What they study most

Atrial Fibrillation, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Hypertension

Studies at this site

• A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study) — Completed
• PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN — Completed
• Management of Gastrointestinal and Urogenital (GI/GU) Bleedings in Atrial Fibrillation Patients Using Pradaxa — Completed
• SMOOTH - Blood Pressure Control in Diabetic/Obese Patients — Completed